MD Anderson Cancer Center reports virtual visits now account for about one-quarter of ambulatory encounters, reflecting a significant shift toward telemedicine in cancer care. In fiscal 2026, the institution conducted more than 295,000 virtual visits, and 60% of patients have used telemedicine at least once, signaling broad adoption across diverse cancer populations.
The scale of virtual care underscores opportunities for AI-enabled care coordination, triage, and remote symptom monitoring to extend specialist access, reduce patient travel, and speed decision-making. While telemedicine improves access and convenience, it also presents challenges for physical exams, treatment monitoring, and data integration, prompting ongoing refinement of workflows and modalities. The MD Anderson experience offers a use case for how AI-driven analytics and digital health tools can augment oncologist expertise, optimize scheduling, and personalize virtual oncology care.
